Oppenheimer Holdings, Inc. (DE) (OPY) News
Filter OPY News Items
OPY News Results
|Loading, please wait...|
OPY News Highlights
- OPY's 30 day story count now stands at 21.
- Over the past 25 days, the trend for OPY's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
- LAW, III and KT are the most mentioned tickers in articles about OPY.
Latest OPY News From Around the Web
Below are the latest news stories about Oppenheimer Holdings Inc that investors may wish to consider to help them evaluate OPY as an investment opportunity.
Barclays''s Karen Short and Oppenheimer''s Rupesh Parikh say earnings expectations are priced in to Costco stock.
ROCHESTER, N.Y., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology Company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, a potent biological mediator, today announced that Elizabeth Evans, PhD, Chief Operating Officer, is scheduled to present at the Oppenheimer & Co. Inc. Fall Healthcare Life Sciences and MedTech Summit.
Top-Rated Invesco Oppenheimer Funds as of 8/31/21 Fund Name, Ticker, Overall Rating, (Risk Grade) Invesco US Managed Volatility R6 USMVX A+ (C+) Invesco PA Municipal A A (C-) Invesco NJ Muni A A- ...
Infinity to Participate in Oppenheimers Fall Healthcare Life Sciences and MedTech Summit and the 3rd Annual Macrophage-directed Therapies Summit
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Sep. 13, 2021-- Infinity Pharmaceuticals, Inc . (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism
FORT LAUDERDALE, Fla., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (Motus GI or the Company), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that its management team is scheduled to present at the Oppenheimer & Co. Inc. Fall Healthcare Summit.
Levin Law, P.A. Announces Investigation of Potential Claims on Behalf of Oppenheimer Customers Who Invested in Horizon Private Equity III
SEC Complaint Alleges Horizon Registered Agent John Woods Lured Clients Into Massive Ponzi Scheme The national securities and class action law firm Levin Law, P.A. is investigating potential claims on behalf of Oppenheimer & Co. customers who invested in Horizon 
HORIZON PRIVATE EQUITY III INVESTOR ALERT: Kurta Law Investigates Ponzi Scheme Allegations on Behalf of Investors
NEW YORK, September 13, 2021--Kurta Law is a securities fraud law firm that can help investors who lost money with the alleged Ponzi scheme Horizon Private Equity III.
A treasure trove of loot plundered by the Nazis for Hitlers personal collection is set to hit the auction block at Sothebys. The 117 pieces of 18th-century Meissen porcelain which form the Oppenheimer collection are currently racking up big advance bids online. The crown jewel a 1727 mantel clock case already has a top bid
This is one guru worth listening to.
Berger Montague Investigates Ponzi Scheme and Potential Violations of Law by John J. Woods and Others Relating to Investments in Horizon Private Equity III, LLC
Philadelphia, Pennsylvania--(Newsfile Corp. - September 8, 2021) - Berger Montague is investigating potential violations of law relating to investments in Horizon Private Equity III, LLC ("Horizon"), promoted and sold by John J. Woods ("Woods") and others associated with him, including Oppenheimer & Co. Inc. The potential claims arise out of an alleged decades-long Ponzi scheme which defrauded more than 400 investors living in 20 states. If you invested in Horizon or have questions ...